Crossref journal-article
Wiley
Journal of Neurochemistry (311)
Abstract

AbstractThe 5′untranslated region (UTR) of the FMR1 gene contains a CGG‐repeat, which may become unstable upon transmission to the next generation. When repeat length exceeds 200, the FMR1 gene generally undergoes methylation‐mediated transcriptional silencing. The subsequent absence of the gene product Fragile X Mental Retardation Protein (FMRP)causes the mental retardation seen in fragile X patients. A CGG‐repeat length between 55 and 200 trinucleotides has been termed the premutation (PM). Predominantly elderly male PM carriers are at risk of developing a progressive neurodegenerative disorder: fragile X‐associated tremor/ataxia syndrome (FXTAS). All PM carriers have elevated FMR1 mRNA levels, in spite of slightly decreased FMRP levels. The presence of intranuclear ubiquitin‐positive inclusions in many brain regions is a neuropathological hallmark of FXTAS. Studies in humans attempting to correlate neuropathological outcomes with molecular measures are difficult because of the limited availability of tissue. Therefore, we have used the expanded CGG‐repeat knock‐in mouse model of FXTAS to examine the relationship between the molecular and neuropathological parameters in brain. We present Fmr1 mRNA and Fmrp levels and the presence of intranuclear inclusions at different repeat lengths. Contrary to existing hypotheses, our results suggest that inclusion formation may not depend on the elevation per se of Fmr1 transcript levels in aged CGG mice.

Bibliography

Brouwer, J. R., Huizer, K., Severijnen, L., Hukema, R. K., Berman, R. F., Oostra, B. A., & Willemsen, R. (2008). CGG‐repeat length and neuropathological and molecular correlates in a mouse model for fragile X‐associated tremor/ataxia syndrome. Journal of Neurochemistry, 107(6), 1671–1682. Portico.

Authors 7
  1. Judith R. Brouwer (first)
  2. Karin Huizer (additional)
  3. Lies‐Anne Severijnen (additional)
  4. Renate K. Hukema (additional)
  5. Robert F. Berman (additional)
  6. Ben A. Oostra (additional)
  7. Rob Willemsen (additional)
References 59 Referenced 81
  1. 10.1007/s00439-004-1086-x
  2. 10.1093/hmg/ddi394
  3. 10.1006/excr.2000.4932
  4. 10.1093/hmg/ddh053
  5. 10.1002/ana.20360
  6. 10.1002/ajmg.a.31559
  7. {'key': 'e_1_2_7_8_1', 'first-page': '2014', 'article-title': 'Fragile X‐associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines', 'volume': '14', 'author': 'Berry‐Kravis E.', 'year': '2007', 'journal-title': 'Mov. Disord.'} / Mov. Disord. / Fragile X‐associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines by Berry‐Kravis E. (2007)
  8. 10.1093/hmg/10.16.1693
  9. 10.1016/j.yexcr.2006.10.002
  10. 10.1016/j.psyneuen.2008.03.011
  11. 10.1093/hmg/ddg331
  12. 10.1016/j.gene.2007.02.026
  13. 10.1093/nar/29.13.2766
  14. 10.1126/science.7732383
  15. 10.1016/0092-8674(91)90283-5
  16. 10.1523/JNEUROSCI.2185-04.2004
  17. 10.1073/pnas.0800048105
  18. 10.1038/ng0297-190
  19. 10.1093/brain/awf184
  20. 10.1093/brain/awh683
  21. 10.1016/j.jns.2006.05.016
  22. 10.1016/S0959-437X(02)00299-X
  23. 10.1086/386296
  24. 10.1212/WNL.57.1.127
  25. 10.1086/420700
  26. 10.1093/brain/awh650
  27. 10.1086/374321
  28. 10.1001/jama.291.4.460
  29. 10.1136/jmg.2006.042374
  30. 10.1093/brain/awh535
  31. 10.1093/hmg/10.14.1449
  32. 10.1212/01.wnl.0000281692.98200.f5
  33. 10.1002/ana.20542
  34. 10.1007/s00439-003-0939-z
  35. 10.1093/emboj/19.17.4439
  36. 10.1016/j.expneurol.2006.08.007
  37. {'key': 'e_1_2_7_38_1', 'first-page': '1252', 'article-title': 'Familial transmission of the FMR1 CGG repeat', 'volume': '59', 'author': 'Nolin S. L.', 'year': '1996', 'journal-title': 'Am. J. Hum. Genet.'} / Am. J. Hum. Genet. / Familial transmission of the FMR1 CGG repeat by Nolin S. L. (1996)
  38. 10.1126/science.252.5009.1097
  39. 10.1093/hmg/ddg298
  40. 10.1093/hmg/9.8.1145
  41. 10.1016/0092-8674(91)90125-I
  42. 10.1017/S1355838202020642
  43. 10.1016/j.tig.2004.08.004
  44. 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J
  45. 10.1093/hmg/ddl121
  46. 10.1093/hmg/1.6.397
  47. 10.1002/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R
  48. 10.1086/302720
  49. 10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V
  50. 10.4161/rna.1.2.1035
  51. 10.1136/jmg.2003.012518
  52. 10.1002/ajmg.b.30482
  53. 10.1261/rna.280807
  54. 10.1093/nar/24.22.4407
  55. 10.1038/363722a0
  56. 10.1016/0092-8674(91)90397-H
  57. 10.1093/hmg/ddg114
  58. 10.1002/(SICI)1096-8628(19960809)64:2<261::AID-AJMG5>3.0.CO;2-X
  59. 10.1007/s00415-004-0558-1
Dates
Type When
Created 16 years, 9 months ago (Nov. 12, 2008, 11:32 a.m.)
Deposited 2 years ago (Aug. 20, 2023, 8:31 p.m.)
Indexed 1 year, 1 month ago (July 29, 2024, 11:50 a.m.)
Issued 16 years, 9 months ago (Nov. 24, 2008)
Published 16 years, 9 months ago (Nov. 24, 2008)
Published Online 16 years, 9 months ago (Nov. 24, 2008)
Published Print 16 years, 9 months ago (Dec. 1, 2008)
Funders 0

None

@article{Brouwer_2008, title={CGG‐repeat length and neuropathological and molecular correlates in a mouse model for fragile X‐associated tremor/ataxia syndrome}, volume={107}, ISSN={1471-4159}, url={http://dx.doi.org/10.1111/j.1471-4159.2008.05747.x}, DOI={10.1111/j.1471-4159.2008.05747.x}, number={6}, journal={Journal of Neurochemistry}, publisher={Wiley}, author={Brouwer, Judith R. and Huizer, Karin and Severijnen, Lies‐Anne and Hukema, Renate K. and Berman, Robert F. and Oostra, Ben A. and Willemsen, Rob}, year={2008}, month=nov, pages={1671–1682} }